Intraperitoneal Compared with Intravenous Meropenem for Peritoneal Dialysis–Related Peritonitis

Li P.K. , Szeto C.C. , Piraino B. , Bernardini J. , Figueiredo A.E. , Gupta A. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010; 30: 393–423. [erratum in: Perit Dial Int 2011; 31:512]

European Committee on Antimicrobial Susceptibility Testing (EUCAST). Neropenem: Rationale for the EUCAST Clinical breakpoints, version 1.5. Växjö, Sweden: EUCAST; 2009. [Available online at: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Rationale_documents/Meropenem_EUCAST_Rationale_Document_1.5_090601. pdf; accessed 10 June 2012]

Van Ende C. , Tintillier M. , Cuvelier C. , Migali G. , Pochet J.M. Intraperitoneal meropenem administration: a possible alternative to the intravenous route. Perit Dial Int 2010; 30: 250–1.

Thalhammer F. , Hörl W.H. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy. Clin Pharmacokinet 2000; 39: 271–9.